These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28235001)

  • 1. Interrater agreement of two adverse drug reaction causality assessment methods: A randomised comparison of the Liverpool Adverse Drug Reaction Causality Assessment Tool and the World Health Organization-Uppsala Monitoring Centre system.
    Mouton JP; Mehta U; Rossiter DP; Maartens G; Cohen K
    PLoS One; 2017; 12(2):e0172830. PubMed ID: 28235001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of WHO-UMC and Naranjo Scales for Causality Assessment of Reported Adverse Drug Reactions.
    Pandit S; Soni D; Krishnamurthy B; Belhekar MN
    J Patient Saf; 2024 Jun; 20(4):236-239. PubMed ID: 38345209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inter-rater agreement between WHO- Uppsala Monitoring Centre system and Naranjo algorithm for causality assessment of adverse drug reactions.
    More SA; Atal S; Mishra PS
    J Pharmacol Toxicol Methods; 2024; 127():107514. PubMed ID: 38768933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of different methods for causality assessment of adverse drug reactions.
    Behera SK; Das S; Xavier AS; Velupula S; Sandhiya S
    Int J Clin Pharm; 2018 Aug; 40(4):903-910. PubMed ID: 30051231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An assessment of reported adverse drug reactions in a Tertiary Care Hospital in South India: A retrospective cross-sectional study.
    Gupta SK; Kumar KD
    Int J Pharm Investig; 2017; 7(4):193-197. PubMed ID: 29692979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial development and testing of an instrument for patient self-assessment of adverse drug reactions.
    Jarernsiripornkul N; Chaipichit N; Pratipanawatr T; Uchaipichat V; Krska J
    Pharmacoepidemiol Drug Saf; 2016 Jan; 25(1):54-63. PubMed ID: 26349635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of agreement between the Naranjo algorithm and WHO-UMC criteria for causality assessment of adverse drug reactions.
    Belhekar MN; Taur SR; Munshi RP
    Indian J Pharmacol; 2014; 46(1):117-20. PubMed ID: 24550597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of the World Health Organization-The Uppsala Monitoring Centre (WHO-UMC) system for the assessment of adverse drug reactions in hospitalized children.
    Tantikul C; Dhana N; Jongjarearnprasert K; Visitsunthorn N; Vichyanond P; Jirapongsananuruk O
    Asian Pac J Allergy Immunol; 2008; 26(2-3):77-82. PubMed ID: 19054924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse Drug Reactions at Nonelective Hospital Admission in Children and Adolescents: Comparison of 4 Causality Assessment Methods.
    Neininger MP; Wehr R; Kiesel LM; Neubert A; Kiess W; Bertsche A; Bertsche T
    J Patient Saf; 2022 Jun; 18(4):318-324. PubMed ID: 35617590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agreement Among Different Scales for Causality Assessment in Drug-Induced Liver Injury.
    Das S; Behera SK; Xavier AS; Velupula S; Dkhar SA; Selvarajan S
    Clin Drug Investig; 2018 Mar; 38(3):211-218. PubMed ID: 29185238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Drug Reactions Reported to a National HIV & Tuberculosis Health Care Worker Hotline in South Africa: Description and Prospective Follow-Up of Reports.
    Njuguna C; Stewart A; Mouton JP; Blockman M; Maartens G; Swart A; Chisholm B; Jones J; Dheda M; Igumbor EU; Cohen K
    Drug Saf; 2016 Feb; 39(2):159-69. PubMed ID: 26547719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot randomised controlled trial to assess the utility of an e-learning package that trains users in adverse drug reaction causality.
    Conroy EJ; Kirkham JJ; Bellis JR; Peak M; Smyth RL; Williamson PR; Pirmohamed M
    Int J Pharm Pract; 2015 Dec; 23(6):447-55. PubMed ID: 26032626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agreement between WHO-UMC causality scale and the Naranjo algorithm for causality assessment of adverse drug reactions.
    Shukla AK; Jhaj R; Misra S; Ahmed SN; Nanda M; Chaudhary D
    J Family Med Prim Care; 2021 Sep; 10(9):3303-3308. PubMed ID: 34760748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imputation of adverse drug reactions: Causality assessment in hospitals.
    Varallo FR; Planeta CS; Herdeiro MT; Mastroianni PC
    PLoS One; 2017; 12(2):e0171470. PubMed ID: 28166274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of the Liverpool Adverse Drug Reaction Avoidability Assessment Tool.
    Bracken LE; Nunn AJ; Kirkham JJ; Peak M; Arnott J; Smyth RL; Pirmohamed M; Turner MA
    PLoS One; 2017; 12(1):e0169393. PubMed ID: 28046035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy in patient-reported adverse drug reactions and their recognition: a mixed-methods study.
    Kampichit S; Srisuriyachanchai W; Pratipanawatr T; Jarernsiripornkul N
    Int J Clin Pharm; 2024 Apr; 46(2):401-410. PubMed ID: 38151687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of two methods to assess causality of adverse drug reactions].
    Kyonen M; Folatre I; Lagos X; Vargas S
    Rev Med Chil; 2015 Jul; 143(7):880-6. PubMed ID: 26361025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An investigation into the avoidability of adverse drug reactions using the LAAT and modified Hallas tools.
    Danjuma MI; Shokri SA; Abubeker IY; Malik AE; Abdallah IMH; Shafei MNE; Fatima H; Mahmoud M; Hussain T; Maghoub Y; Sajid J; Zouki ANE
    Medicine (Baltimore); 2020 Jan; 99(1):e18569. PubMed ID: 31895800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agreement of expert judgment in causality assessment of adverse drug reactions.
    Arimone Y; Bégaud B; Miremont-Salamé G; Fourrier-Réglat A; Moore N; Molimard M; Haramburu F
    Eur J Clin Pharmacol; 2005 May; 61(3):169-73. PubMed ID: 15827761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of Causality Assessment for an Automated Detection of Safety Signals: An Example Using the French Pharmacovigilance Database.
    Berbain T; Pariente A; Miremont-Salamé G; Grandvuillemin A; Micallef J; Chouchana L; Benkebil M; Théophile H;
    Drug Saf; 2020 Mar; 43(3):243-253. PubMed ID: 31974775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.